Scribe Therapeutics logo
Healthcare & Life Sciences

Scribe Therapeutics

United Stateswww.scribetx.com/

Scribe Therapeutics is a series b startup based in United States. 1 investor tracked.

Activeseries-b
series-b
Stage
2
Investors

About Scribe Therapeutics

Scribe Therapeutics is a startup based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.

Scribe Therapeutics develops CRISPR-based genetic medicines, initially focused on cardiometabolic disease.

Explore Scribe Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States